| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $16.6B | — | — | — | — |
| Op. Income | $2.7B | — | — | — | — |
| Gross Margin | 69.4% | — | — | — | — |
| Net Margin | 12.7% | — | — | — | — |
| EPS (Diluted) | $169.22 | — | — | — | — |
| Free Cash Flow | $2.6B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $16.6B |
| Cost of Revenue | $5.1B |
| GROSS PROFIT | $11.5B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $8.8B |
| Operating Expenses | $8.8B |
| Cost & Expenses | $13.9B |
| OPERATING INCOME | $2.7B |
| Interest Income | $0 |
| Interest Expense | $206M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $2.7B |
| Income Tax Expense | $580M |
| Net Income from Continuing Ops | $2.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.1B |
| D&A | $0 |
| EBIT | $2.9B |
| EBITDA | $2.9B |
| EPS | $170 |
| EPS Diluted | $169 |
| Item | Amount |
|---|---|
| REVENUE | $16.6B |
| Cost of Revenue | $5.1B |
| GROSS PROFIT | $11.5B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $8.8B |
| Operating Expenses | $8.8B |
| Cost & Expenses | $13.9B |
| OPERATING INCOME | $2.7B |
| Interest Income | $0 |
| Interest Expense | $206M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $2.7B |
| Income Tax Expense | $580M |
| Net Income from Continuing Ops | $2.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.1B |
| D&A | $0 |
| EBIT | $2.9B |
| EBITDA | $2.9B |
| EPS | $170 |
| EPS Diluted | $169 |
| Item | Amount |
|---|---|
| Net Income | $2.1B |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$379M |
| Change in Working Capital | $1.0B |
| OPERATING CASH FLOW | $2.8B |
| Capital Expenditure | -$207M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$1.3B |
| NET CASH FROM INVESTING | -$1.3B |
| Net Debt Issuance | -$29M |
| Common Stock Repurchased | -$430M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$10M |
| NET CASH FROM FINANCING | -$1.1B |
| FREE CASH FLOW | $2.6B |
| Net Change in Cash | $411M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $4.6B |
| Short-Term Investments | $17.8B |
| Net Receivables | $4.0B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $26.4B |
| PP&E (Net) | $0 |
| Goodwill | $2.8B |
| Intangible Assets | $1.5B |
| Long-Term Investments | $33.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$33.6B |
| TOTAL NON-CURRENT ASSETS | $4.4B |
| TOTAL ASSETS | $68.9B |
| Account Payables | $1.7B |
| Short-Term Debt | $195M |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$1.9B |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $4.2B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $2M |
| Other Non-Current Liabilities | $27.3B |
| TOTAL NON-CURRENT LIABILITIES | $32.1B |
| TOTAL LIABILITIES | -$18.6B |
| Common Stock | $3.7B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $15.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$109M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $18.6B |
| Minority Interest | $506M |
| TOTAL EQUITY | $19.1B |
| TOTAL LIABILITIES & EQUITY | $51.2B |
| Total Debt | $5.0B |
| Net Debt | $411M |
